Scilex seeks FDA nod for ELYXYB in acute pain management
PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a pharmaceutical company with a current market capitalization of ...
Medscape2d
Acute Postoperative Pain Management in the Older Patient
Acute pain management in the older adult is both challenging and rewarding. This review addresses the difficulty with assessment of pain in the older adult, variations in the pain experience of ...
The Stanford Daily1h
Conference highlights advances in human and animal pain relief
Stanford Effective Altruism, Stanford Student Pre-Veterinary Committee and Stanford Animal Service Project talk about the ...
Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)
SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido ® is a registered ...
Scilex to file SNDA with FDA for ELYXYB
Scilex (SCLX) announced that it will be filing today of a Supplemental New Drug Application, SNDA, with the FDA for ELYXYB in acute pain ...
The Bluffton Icon3d
Weekend Doctor: Goals for effective pain management
Pain management is a team effort. We act as a consultative service, focusing on the patient’s specific pain diagnosis while ...
sicklecellanemianews6d
Improving sickle cell pain management requires more research
Columnist Oluwatosin Adesoye discusses the ongoing dilemma with sickle cell pain management for both patients and healthcare ...
Business Wire21d
A Novel Non-Opioid Multimodal Analgesic from Xgene Pharmaceutical Reduces Pain and a Need for Opioid Consumption in a Post-Surgical Pain Trial
Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain following bunionectomy compared to placebo. XG005 eliminated the need to use any ...
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials
It can generate billions in revenue from both acute and possibly chronic pain. If approved, it would give Vertex ...
BMJ11d
Acute painful crisis in sickle cell disease: transfusion is not a benign treatment
Charles and colleagues’ overview of management of acute pain crisis in sickle cell disease is welcome,1 especially as patients move away from city centres to areas that typically have a less ...